The Risk of Transitioning From Substance Use Induced Psychosis to Schizophrenia Spectrum Disorder and Bipolar Disorder

Dr. Mark Olfson (Columbia University) discusses the links between opioid prescribing and suicide risk in the United States. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses how issues of substance use disorder draw together the rest of the June issue.

Transcript

• Olfson interview [00:46]
• Geographic commuting areas [01:06]
• Opioid prescription measures [02:10]
• Rates of opioid prescription and suicide [03:27]
• Youngest age cohorts as outliers [04:19]
• Regional variations [04:57]
• Limitations [05:17]
• Clinical implications [05:55]
• What’s next for your research? [06:21]
• Kalin interview [06:42]
• Olfson et al. [07:00]
• Vickers-Smith et al. [08:36]
• Rognli et al. [10:44]
• Garrison et al. [12:51]

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Stitcher, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org